Phase 1 Anaphylaxis Clinical Trials

4 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–4 of 4 trials

Recruiting

Phase 1Phase 2

UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies

Peanut allergyPeanut-Induced Anaphylaxis

Ukko Inc40 enrolled5 locationsNCT07349212

Recruiting

Phase 1

Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing, Immunotherapy or Oral Challenges

AnaphylaxisHypersensitivity

Dr. George Luciuk100 enrolled1 locationNCT07038746

Recruiting

Phase 1

Use of Dexamethasone in Prevention of the Second Phase or a Biphasic Reaction of Anaphylaxis

Anaphylaxis

Hamad Medical Corporation210 enrolled1 locationNCT03523221

Completed

Phase 1

A pilot study of the bioavailability and pharmacokinetics of epinephrine after administration of ARS-1 and intramuscular epinephrine to healthy volunteers

Anaphylaxis

ARS Pharmaceuticals PTY LTD27 enrolled1 locationACTRN12619001745134